NewLink Genetics to Participate in the Cantor Global Healthcare Conference

AMES, Iowa, Sept. 18, 2018 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ: NLNK) announced today that the Company will present at the 2018 Cantor Global Healthcare Conference on Wednesday, October 3, 2018, at 4:00PM ET in New York, New York.

A live webcast of the presentation will be available on the Company’s website at www.newlinkgenetics.com in the “Investors & Media” section under “Events and Presentations.” An archived edition of the presentation will be available on NewLink Genetics’ website later that day.

About NewLink Genetics Corporation

NewLink Genetics is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing novel immuno-oncology product candidates to improve the lives of patients with cancer. NewLink Genetics' leading drug candidate, indoximod, is an investigational, orally available small molecule designed to harness multiple components of the immune system to combat cancer. For more information, please visit www.newlinkgenetics.com and follow us on Twitter @NLNKGenetics.

Investor Contact:

Lisa MillerDirector of Investor RelationsNewLink Genetics515-598-2555[email protected]

Media Contact:

Sharon CorreiaVP, Integrated CommunicationsLaVoieHealthScience617-374-8800, ext. 105[email protected]

Source: NewLink Genetics Corporation

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Quebec Brokerage Qubit Insurance Announces New Data on Coverage Shortfalls as Rebuilding Costs Rise
• “2025 China Yearbook” Debuts at São Paulo International Book Fair
• How to choose a funding firm in 2026: what traders should demand before paying for an evaluation